Opioid and Other Substance Use Disorders Study Committee.
The bill: • Requires a carrier that provides coverage for opiate antagonists to reimburse a hospital if the hospital provides a covered person with an opiate antagonist upon discharge (section 1 of the bill); • Allows a pharmacist or pharmacy technician to sell a nonprescription syringe or needle to any person (sections 2 and 5); • Extends civil and criminal immunity for a person who acts in good faith to furnish or administer an opiate antagonist to an individual the person believes to be suffering an opiate-related drug overdose when the opiate antagonist was expired (sections 3 and 4); • Removes the requirement that entities first receive local board of health approval before operating a clean syringe exchange program (sections 6 and 7); and • Provides that money in the harm reduction grant program cash fund is continuously appropriated to the department of public health and environment for purposes of the harm reduction grant program and establishes an annual appropriation of an amount equal to the appropriation for the 2019-20 fiscal year plus $250,000 (section 8).
Year
2020
Current status
- Sent to the Governor (06/29/2020)
- Senate Third Reading Passed - No Amendments (06/11/2020)
- Introduced In Senate - Assigned to State, Veterans, & Military Affairs (06/09/2020)
- House Third Reading Passed - No Amendments (06/09/2020)
- House Committee on Health & Insurance Refer Amended to Appropriations (02/19/20)
- Introduced In House - Assigned to Health & Insurance (01/08/2020)